Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
S Nooraei, H Bahrulolum, ZS Hoseini… - Journal of …, 2021 - Springer
Virus-like particles (VLPs) are virus-derived structures made up of one or more different
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …
molecules with the ability to self-assemble, mimicking the form and size of a virus particle but …
Multifunctional biomolecule nanostructures for cancer therapy
J Wang, Y Li, G Nie - Nature Reviews Materials, 2021 - nature.com
Biomolecule-based nanostructures are inherently multifunctional and harbour diverse
biological activities, which can be explored for cancer nanomedicine. The supramolecular …
biological activities, which can be explored for cancer nanomedicine. The supramolecular …
Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs): toward better engineering of VLPs
J Zepeda-Cervantes, JO Ramírez-Jarquín… - Frontiers in …, 2020 - frontiersin.org
Virus-like particles (VLPs) have been shown to be strong activators of dendritic cells (DCs).
DCs are the most potent antigen presenting cells (APCs) and their activation prompts the …
DCs are the most potent antigen presenting cells (APCs) and their activation prompts the …
Nanomedicine for increasing the oral bioavailability of cancer treatments
Oral administration is an appealing route of delivering cancer treatments. However, the
gastrointestinal tract is characterized by specific and efficient physical, chemical, and …
gastrointestinal tract is characterized by specific and efficient physical, chemical, and …
Review of the role of nanotechnology in overcoming the challenges faced in oral cancer diagnosis and treatment
Throughout the world, oral cancer is a common and aggressive malignancy with a high risk
of morbidity, mortality, and recurrence. The importance of early detection in cancer …
of morbidity, mortality, and recurrence. The importance of early detection in cancer …
Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
The mRNA vaccine platform has offered the greatest potential in fighting the COVID-19
pandemic owing to rapid development, effectiveness, and scalability to meet the global …
pandemic owing to rapid development, effectiveness, and scalability to meet the global …
Current trends of targeted drug delivery for oral cancer therapy
M Zhang, J Liang, Y Yang, H Liang, H Jia… - … in bioengineering and …, 2020 - frontiersin.org
Oral cancer is an aggressive tumor that invades the local tissue and can cause metastasis
and high mortality. Conventional treatment strategies, eg, surgery, chemotherapy, and …
and high mortality. Conventional treatment strategies, eg, surgery, chemotherapy, and …
Engineering a nanoscale Al‐MOF‐armored antigen carried by a “trojan horse”‐like platform for Oral vaccination to induce potent and long‐lasting immunity
YB Miao, WY Pan, KH Chen, HJ Wei… - Advanced Functional …, 2019 - Wiley Online Library
Vaccination via the oral administration of an antigen faces many challenges, including
gastrointestinal (GI) proteolysis and mucosal barriers. To limit GI proteolysis, a …
gastrointestinal (GI) proteolysis and mucosal barriers. To limit GI proteolysis, a …
Development of SARS-CoV-2 vaccines: should we focus on mucosal immunity?
L Moreno-Fierros, I García-Silva… - Expert Opinion on …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by the SARS-CoV-2 virus is having an unprecedented
impact on global health derived from its quick spread, which is attributed to its high stability …
impact on global health derived from its quick spread, which is attributed to its high stability …
[HTML][HTML] The Influence of the Protozoan Giardia lamblia on the Modulation of the Immune System and Alterations in Host Glucose and Lipid Metabolism
S Klimczak, K Packi, A Rudek, S Wenclewska… - International Journal of …, 2024 - mdpi.com
Giardia lamblia, the cause of giardiasis, significantly impacts patients with metabolic
disorders related to insulin resistance (IR). Both giardiasis and metabolic disorders share …
disorders related to insulin resistance (IR). Both giardiasis and metabolic disorders share …